Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Another 4 out of 10 patients said they no longer needed the medication, while less than a third cited financial and insurance barriers
Your body thrives on predictable dosing schedules, and maintaining seven-day intervals ensures stable medication levels in your bloodstream
8, Unit 8.12
Phase 2 trial participants lost an average of ~24% of their body weight over 48 weeks, compared to roughly 1517% with semaglutide and 2022% with tirzepatide
If the two disagree, do not inject
Who should avoid GHK-Cu entirely Wilson's disease or any copper metabolism disorder Active malignancy until more evidence exists Pregnancy and breastfeeding Known copper sensitivity Anyone unable to maintain sterile technique for injection When unsure, talk to us before starting anything
US$ 23.40
US$ 29.72
US$ 26.97
US$ 20.78
